REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Laboratorios Provet S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Laboratorios Provet S.A.S. Profile Updated: November 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

La fabricacion distribucion exportacion e importacion de productos farmaceuticos de uso humano y veterinario e instrumental y demas implementos afines a ambos ramos.1

Headquarters
Autopista Medellin Km7 Celta Trade Park Pl 77
Funza; Cundinamarca;

Contact Details: Purchase the Laboratorios Provet S.A.S. report to view the information.

Website: http://www.laboratoriosprovet.com

Basic Information
Total Employees:
Purchase the Laboratorios Provet S.A.S. report to view the information.
Outstanding Shares:
Purchase the Laboratorios Provet S.A.S. report to view the information.
Registered Capital:
Purchase the Laboratorios Provet S.A.S. report to view the information.
Incorporation Date:
September 28, 1985
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Company Performance
Financial values in the chart are available after Laboratorios Provet S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
7.92%▲
Total operating revenue
6.95%▲
Operating profit (EBIT)
-8.07%▼
EBITDA
-10.94%▼
Net Profit (Loss) for the Period
-19.09%▼
Total assets
-1.97%▼
Total equity
-23.59%▼
Operating Profit Margin (ROS)
-5.96%▼
Net Profit Margin
-6.86%▼
Return on Equity (ROE)
3.59%▲
Debt to Equity Ratio
0%
Quick Ratio
-0.16%▼
Cash Ratio
-0.15%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo